<DOC>
	<DOCNO>NCT02023554</DOCNO>
	<brief_summary>Macrolides potent inhibitor cytochrome P450 isoenzyme 3A4（CYP3A4）and thus interfere pharmacokinetics many drug metabolise enzyme like theophylline.The aim study determine whether azithromycin effect theophylline metabolism patient .</brief_summary>
	<brief_title>Drug Interaction Study Azithromycin Theophylline</brief_title>
	<detailed_description>In non-blinded , auto-control study , patient Chronic Obstructive Pulmonary Disease（COPD）or asthma serve control 2-week treatment phase.The subject co-administered oral dos sustain release theophylline ( 100mg tablet , twice daily ) azithromycin ( 2x250mg capsule , daily ) first week.Then patient receive theophylline therapy alone dose second week.Blood sample measurement theophylline plasma concentration collect Days 8 15 prior dosing.All adverse event whether elicited query , spontaneously report observed clinic staff evaluate investigator report subject 's case report form .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>patient COPD asthma，aged 1875 year ; regularly visit hospital ; meeting indication azithromycin theophylline simultaneously ; patient renal hepatic dysfunction ; patient congestive heart failure ; patient hypothyroidism hyperthyroidism ; patient take drug likely affect theophylline metabolism precede week ; patient severe chronic obstructive pulmonary disease , asthma respiratory infection ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>azithromycin</keyword>
	<keyword>theophylline</keyword>
	<keyword>CYP3A4</keyword>
</DOC>